Blood-membrane interaction in continuous renal replacement therapies

Current Opinion in Critical Care

Volumn 3, Issue 6, 1997, Pages 420-425

  Silvester, William ^a  

^a AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0007539340     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075198-199712000-00004     Document Type: Article

References (58)

1. Radovich JM: Composition of polymer membranes for therapies of end-stage renal disease. Contrib Nephrol 1995, 113:11-24.
2. Vroman L: The life of an artificial device in contact with blood: initial events and their effect on its final state. Bull N Y Acad Med 1988, 64:352-357.
3. Hakim RM: Clinical implications of haemodialysis membrane biocompatibility. Kidney Int 1993, 44:484-494.
4. Hakim RM: Recent advances in the biocompatibiltty of haemodialysis membranes. Nephrol Dial Transplant 1995, 10:7-11.
5. Holmes CJ: Hemodialyzer performance: biological indices. Artif Organs 1995, 19:1126-1135.
6. Cheung AK, Parker CJ, Wilcox LA, Janatova J: Activation of complement by haemodialysis membranes: polyacrylonitrile binds more C3a than cuprophane. Kidney Int 1990, 37:1055-1059.
7. Mulvihill J, Cazenave JP, Mazzucotelli JP, Crost T, Collier C, Renaux JL, Pusineri C: Minimodule dialyser for quantitative ex vivo evaluation of membrane haemocompatibility in humans: comparison of acrylonitrile copolymer, cuprophane and polysulphone hollow fibres. Biomaterials 1992, 13:527-536.
8. Gasche Y, Pascual M, Suter PM, Favre H, Chevrolet JC, Schifferli JA: Complement depletion during haemofiltration with polyacrilonitrile membranes. Nephrol Dial Transplant 1996, 11:117-119.
9. Silvester W, Honore P, Sieffert E, Valentine J, Wagle S, Smithies M, Bihari D: Interleukins 6 and 8, tumour necrosis factor alpha and complement D clearance by polyacrylonitrile and polysulphone membranes during haemofiltration in critically ill patients [abstract]. Blood Purit 1997, 15:A127.
10. Haeffner-Cavaillon N, Cavaillon JM, Laude M, Kazatchkine MD: C3a(C3adesArg) induces production and release of interleukin 1 by cultured human monocytes. J Immunol 1987, 139:794-799.
11. Schindler R, Linnenweber S, Schultz M, Oppermann M, Dinarello CA, Shaldon S, Koch KM: Gene expression of Interleukin-1B during haemodialysis. Kidney Int 1993, 43:712-721.
12. Schindler R, Gelfand JA, Dinarello CA: Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1 and tumor necrosis factor: translational signal provided by lipopolysaccharide or IL-1 itself. Blood 1990, 76:1631-1638.
13. Okusawa S, Dinarello CA, Yancey KB, Endres S, Lawley TJ, Frank MM, Burke JF, Gelfand JA: C5a induction of human interleukin 1: synergistic effect with endotoxin or interferon-gamma. J Immunol 1987, 139:2635-2640.
14. Lin YF, Chang DM, Shaio MF, Lu KC, Chyr SH, Li BL, Sheih SD: Cytokine production during haemodialysis: effects of dialytic membrane and complement activation. Am J Nephrol 1996, 16:293-299.
15. Marchant A, Tielemans C, Husson CP, Gastaldello K, Schurmans T, De Groote D, Duchow J, Vanherweghem JL, Goldman M: Cuprophane haemodialysis induces upregulation of LPS receptor (CD14) on monocytes: role of complement activation. Nephrol Dial Transplant 1996, 11:657-662.
16. Tielemans CL, Delville JP, Husson CP, Madhoun P, Lambrechts AM, Goldman M, Vanherweghem JL: Adhesion molecules and leukocyte common antigen on monocytes and granulocytes during haemodialysis. Clin Nephrol 1993, 39:158-165.
17. Schulman G, Fogo A, Gung A, Badr K, Hakim R: Complement activation retards resolution of acute ischemic renal failure in the rat Kidney Int 1991, 40:1069-1074.
18. Gung A, Schulman G, Hakim R: Haemodialysis membrane choice influences maintenance of residual renal function (RRF) in an animal model [abstract]. J Am Soc Nephrol 1991, 2:327.
19. van de Wetering J, Westendorp RGJ, van der Hoeven JG, Stolk B, Feuth JDM, Chang PC: Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage. J Am Soc Nephrol 1996, 7:145-150.
20. Stefanidis I, Hagel J, Frank D, Maurin N: Hemostatic alterations during continuous venovenous hemofiltration in acute renal failure. Clin Nephrol 1996, 46:199-205.
21. Verbeelen D, Jochmans K, Herman AG, Van der Niepen P, Sennesael J, De Waele M: Evaluation of platelets and hemostasis during haemodialysis with six different membranes. Nephron 1991, 59:567-572.
22. Ward RA: Effects of haemodialysis on coagulation and platelets: are we measuring membrane biocompatibility? Nephrol Dial Transplant 1995, 10:12-17.
23. Silvester W, Honore P, Sieffert E, Valentine J, Wagle S, Smithies M, Bihari D: Effect of heparin, prostacyclin or combination, and effect of polyacrylonitrile or polysulphone membranes on filter survival in critically ill patients on continuous veno-venous haemofiltration [abstract]. Blood Puril 1997, 15: A124.
24. Schulman G, Hakim RM, Arias R, Silverberg M, Kaplan AP, Arbeit L: Bradykinin generation by dialysis membranes: possible role in anaphylactic reaction. J Am Soc Nephrol 1993, 3:1563-1569.
25. Parnes EL, Shapiro WB: Anaphylactoid reactions in haemodialysis patients treated with AN69 dialyzers. Kidney Int 1991, 40:1148-1152.
26. Guastoni C, Tetta C, Hoenich NA, Gervasio R, Sereni L, Tessore E, Wratten ML, Civati G: Mechanisms and kinetics of the synthesis and release of platelet-activating factor (PAF) by polyacrylonitrile membranes. Clin Nephrol 1996, 46:132-138.
27. Ronco C, Tetta C, Lupi A, Galloni E, Bettini MC, Sereni L, Mariano F, DeMartino A, Montrucchio G, Camussi G, La Greca G: Removal of platelet-activating factor in experimental continuous arteriovenous hemofiltration. Crit Care Med 1995, 23:99-107.
28. Boldt J, Menges T, Wollbruck M, Sonneborn S, Hempelmann G: Continuous hemofiltration and platelet function in critically ill patients. Crit Care Med 1994, 22:1155-1160.
29. Sreedhara R, Itagaki I, Lynn B, Hakim RM: Defective platelet aggregation in uremia is transiently worsened by haemodialysis. Am J Kidney Dis 1995, 25:555-563.
30. Journois D, Chanu D, Pouard P, Mauriat P, Safran D: Assessment of standardized ultrafiltrate production rate using prostacyclin in continuous venovenous hemofiltration. Contrib Nephrol 1991, 93:202-204.
31. Zaoui P, Hakim RM: The effects of the dialysis membrane on cytokine release. J Am Soc Nephrol 1994, 4:1711-1718.
32. Qian J, Yu Z, Dai H, Zhang Q, Chen S: Influence of haemodialysis membranes on gene expression and plasma levels of interleukin-1B. Artif Organs 1995, 19:842-846.
33. Dinarello CA: Interleukin-1 and interleukin-1 receptor antagonist production during haemodialysis: which cytokine is a surrogate marker for dialysis-related complications? Nephrol Dial Transplant 1995, 10:25-28.
34. Roccatello D, Mazzucco G, Coppo R, Piccoli G, Rollino C, Scalzo B, Guerra MG, Cavalli G, Giachino O, Amore A, et al.: Functional changes of monocytes due to dialysis membranes. Kidney Int 1989, 35:622-631.
35. Silvester W: Mediator removal with CRRT: complement and cytokines. Am J Kidney Dis 1997, 30(suppl 4):S38-S43.
36. Kaupke CJ, Zhang J, Cesario T, Yousefi S, Akeel N, Vaziri ND: Effect of haemodialysis on leukocyte adhesion receptor expression. Am J Kidney Dis 1996, 27:244-252.
37. Rabb H, Calderon E, Bittle PA, Ramirez G: Alterations in soluble intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in hemodialysis patients. Am J Kidney Dis 1996, 27:239-243.
38. Ward RA: Phagocytic cell function as an index of biocompatibility. Nephrol Dial Transpl 1994, 9:46-56.
39. Thylen P, Fernvik E, Lundahl J: Cell surface receptor modulation on monocytes and granulocytes during clinical and experimental haemodialysis. Am J Nephrol 1995, 15:392-400.
40. Carreno MP, Stuard S, Bonomini M, Settefrati N, Tetta C, Albertazzi A, Haeffner-Cavaillon N: Cell-associated adhesion molecules as early markers of bioincompatibility. Nephrol Dial Transplant 1996, 11:2248-2257.
41. Malmros C, Blomquist S, Dahm P, Martensson L, Thorne J: Nitric oxide inhalation decreases pulmonary platelet and neutrophil sequestration during extracorporeal circulation in the pig. Crit Care Med 1996, 24:845-849.
42. Bohler J, Schollmeyer P, Dressel B, Dobos G, Horl WH: Reduction of granulocyte activation during haemodialysis with regional citrate anticoagulation: dissociation of complement activation and neutropenia from neutrophil degranulation. J Am Soc Nephrol 1996, 7:234-241.
43. Mansch GM, Karnaoukhova S, Chang SH, Rus H, Nicolescu F, Deppisch R, Meissner C, Ludwig H, Ritz E: Activation of human neutrophils after contact with cellulose-based haemodialysis membranes: intracellular calcium signaling in single cells. Nephrol Dial Transplant 1996, 11:2453-2460.
44. Haag-Weber M, Mai B, Deppisch R, Horl WH: Studies of biocompatibility of different dialyzer membranes: role of complement system, intracellular calcium and inositol-triphosphate. Clin Nephrol 1994, 41:245-251.
45. Vanholder R, Ringoir S, Dhondt A, Hakim RM: Phagocytosis in uremic and haemodialysis patients: a prospective and cross sectional study. Kidney Int 1991, 39:320-327.
46. Himmelfarb J, Ault KA, Holbrook D, Leeber DA, Hakim RM: Intradialytic granulocyte reactive oxygen species production: a prospective, crossover trial. J Am Soc Nephrol 1993, 4:178-186.
47. Hornych A, Remy P, Luong N, Aumont J, Bariety J: Biocompatibility of haemodialysis membranes: haemodialysis-related leukotriene B4 and C4 generation. Nephron 1996, 74:11-18.
48. Schiffl H, Lang SM, Konig A, Strasser T, Haider MC, Held E: Biocompatible membranes in acute renal failure: prospective case-controlled study. Lancet 994, 344:570-572.
49. Amore A, Bonaudo R, Ghigo D, Arese M, Costamagna C, Cirina P, Gianoglio B, Perugini L, Coppo R: Enhanced production of nitric oxide by blood-dialysis membrane interaction. J Am Soc Nephrol 1995, 6:1278-1283.
50. Rysz J, Luciak M, Kedziora J, Blaszczyk J, Sibinska E: Nitric oxide release in the peripheral blood during haemodialysis. Kidney Int 1997, 51:294-300.
51. Roccatello D, Mengozzi G, Alfieri V, Pignone E, Menegatti E, Cavalli G, Cesano G, Rossi D, Formica M, Inconis T, et al.: Early increase in blood nitric oxide, detected by electron paramagnetic resonance as nitrosyl-haemoglobin, in haemodialysis. Nephrol Dial Transplant 1997, 12:292-297.
52. Cosentino F, Chaff C, Piedmonte M: Risk factors influencing survival in ICU acute renal failure. Nephrol Dial Transplant 1994, 9:179-182.
53. Liano F, Pascual J, and the Madrid Acute Renal Failure Study Group: Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Kidney Int 1996, 50:811-818.
54. Neveu H, Kleinknecht D, Brivet F, Loirat Ph, Landais P, and the French Study Group on Acute Renal Failure: Prognostic factors in acute renal failure due to sepsis: results of a prospective multicentre study. Nephrol Dial Transplant 1996, 11:293-299.
55. Valeri A: Biocompatible membranes (BCM) in acute renal failure (ARF): a study in post-cadaveric renal transplant acute tubular necrosis (ATN) [abstract]. J Am Soc Nephrol 1994, 5:481.
56. Hakim RM, Wingard RL, Parker RA: Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med 1994, 331:1338-1442.
57. Hakim RM, Tolkoff-Rubin N, Himmelfarb J, Wingard RL, Parker RA: A multicenter comparison of bioincompatible (BICM) and biocompatible (BCM) membranes in the treatment of acute renal failure (ARF) [abstract]. J Am Soc Nephrol 1994, 5:394.
58. Ishihara K, Fukumoto K, Miyazaki H: Improvement of hemocompatibility on a cellulose dialysis membrane with a novel biomedical polymer having a phospholipid polar group. Artif Organs 1994, 18:559-564.